Cooper, Cyrus http://orcid.org/0000-0003-3510-0709
Chapurlat, Roland
Al-Daghri, Nasser
Herrero-Beaumont, Gabriel
Bruyère, Olivier http://orcid.org/0000-0003-4269-9393
Rannou, François
Roth, Roland
Uebelhart, Daniel
Reginster, Jean-Yves http://orcid.org/0000-0001-6290-752X
Article History
First Online: 9 May 2019
Compliance with Ethical Standards
:
: The Working Group was entirely funded by ESCEO, a Belgian not-for-profit organization. ESCEO receives unrestricted educational grants, to support its educational and scientific activities, from non-governmental organizations, not-for-profit organizations, and non-commercial and corporate partners. The choice of topics, participants, content, and agenda of the working groups as well as the writing, editing, submission, and reviewing of the manuscript is under the sole responsibility of ESCEO, without any influence from third parties.
: Olivier Bruyère reports grants from Biophytis, IBSA, MEDA, Servier, SMB, and Theramex, outside of the submitted work. Cyrus Cooper reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda, and UCB, outside of the submitted work. Jean-Yves Reginster reports grants from IBSA-Genevrier, Mylan, CNIEL, and Radius Health (through institution), consulting fees from IBSA-Genevrier, Mylan, CNIEL, Radius Health, and Pierre Fabre, fees for participation in review activities from IBSA-Genevrier, MYLAN, CNIEL, Radius Health, and Teva, payment for lectures from AgNovos, CERIN, CNIEL, Dairy Research Council, Echolight, IBSA-Genevrier, Mylan, Pfizer Consumer Health, Teva, and Theramex, outside of the submitted work. François Rannou reports grants from APHP, INSERM, University Paris Descartes, and Arthritis (Road Network), and consulting fees from Pierre Fabre, Expanscience, Thuasne, Servier, Genevrier, Sanofi Aventis, and Genzyme, outside of the submitted work. Roland Chapurlat, Nasser Al-Daghri, Gabriel Herrero-Beaumont, Roland Roth, and Daniel Uebelhart have not conflicts of interest that are directly relevant to the content of this article.